Article Text

Download PDFPDF
Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes
  1. A B Csoka1,
  2. H Cao2,
  3. P J Sammak1,
  4. D Constantinescu1,
  5. G P Schatten1,
  6. R A Hegele2
  1. 1Pittsburgh Development Center, Magee-Womens Research Institute, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
  2. 2Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, London, Ontario, Canada
  1. Correspondence to:
 Robert A Hegele
 MD, FRCPC, FACP, Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406-100 Perth Drive, London, Ontario, Canada N6A 5K8; hegelerobarts.ca

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Hutchinson-Gilford Progeria Syndrome (HGPS, OMIM 176670), commonly called “progeria”, occurs in ≈1 in 8 million births and displays striking features of “premature aging”.1,2 HGPS recapitulates most of the pathologies of normal aging at an accelerated rate, with sparing of the nervous system.3 Children with HGPS usually appear normal in early infancy, but at about six months of age begin to experience profound growth delay.4 Scalp hair, eyebrows, and eyelashes are typically lost resulting in total alopecia.5 A gradual, almost complete lipodystrophy begins in infancy, and the skin acquires an abnormally aged appearance with prominent veins. In some children osteolysis may affect the clavicles, terminal phalanges, and acetabulum, and sometimes even more severe bone deformities occur,6 including generalised osteoporosis leading to repeated fractures7 and degenerative joint changes leading to coxa valga and hip dislocation.8 Affected children as young as five years develop widespread atherosclerosis including the coronary arteries and aorta,9 often resulting in death by myocardial infarction or stroke in the early teens.10 Recently, the genetic basis for HGPS was shown to be heterozygosity for a de novo point mutation in LMNA codon 608 in exon 11 (c. 1824 C>T).11–13 This single base substitution partially activates a cryptic splice site, leading to an altered lamin A protein in which 50 amino acids near the carboxyl terminus are deleted. The LMNA gene codes for both lamin A and lamin C, but the mutation only affects the structure of lamin A because exon 11 of LMNA is not present in lamin C mRNA.

HGPS is a recent member of the family of “laminopathies”, disorders caused by mutations in LMNA.14,15 Others include autosomal dominant (AD) and autosomal recessive (AR) Emery-Dreifuss muscular dystrophy type 2 (EDMD2), a form of AD …

View Full Text

Footnotes

  • This work was supported by grants from Canadian Institutes for Health Research (MT13430), the Canadian Genetic Diseases Network and the Blackburn Group to RAH, and NIH support to GPS and the Pittsburgh Development Center.

  • Dr Hegele holds a Canada Research Chair (Tier I) in Human Genetics and a Career Investigator award from the Heart and Stroke Foundation of Ontario.